NL-OMON30282已完成3 期
Randomised multicentre trial comparing bilateral subthalamic nucleus DBS and bilateral globus pallidus internus DBS for advanced Parkinson*s disease - N-STAPS
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 128
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Inclusion criteria are idiopathic Parkinson's disease and * despite optimal pharmacological treatment * at least one of the following symptoms: severe response fluctuations, dyskinesias, painful dystonias, or bradykinesia.
排除标准
- •Exclusion criteria are: age below 18 years, previous functional stereotactic neurosurgery, Hoehn and Yahr stage 5 at the best moment during the day, a MATTIS dementia rating scale score of 120 or less, current psychosis or depression, and contraindications for stereotactic neurosurgery such as a physical disorder making surgery hazardous (severe hypertension, blood coagulation disorder, severe dysphagia, or dysarthria).
研究者
相似试验
已完成
不适用
Randomised double-blind multicentre trial comparing bilateral subthalamic nucleus deep brain stimulation and bilateral globus pallidus deep brain stimulation for advanced Parkinson's diseaseParkinson's diseaseNervous System DiseasesISRCTN85542074Academic Medical Centre (AMC) (Netherlands)128
已完成
不适用
Multicentre, randomised, double-blind trial comparing yellow fever vaccines from 17D and WHO 17DD-213/77 substrains in childreYellow feverISRCTN72367932Bio-Manguinhos (Brazil)3,500
招募中
3 期
Multicenter double-blind randomized comparative parallel study with concomitant therapy of 3 drugs, aprepitant + dexamethasone+palonosetron or aprepitant + dexamethasone+ granisetron, for prevention of nausea/vomiting in breast cancer patients receiving AC therapyBreast CancerJPRN-UMIN000007882Juntendo Clinical Research Support Center660
进行中（未招募）
不适用
A Multicenter Randomized Double-Blind Trial Comparing Rosiglitazone to Placebo for the Prevention of Atherosclerosis Progression after Coronary Bypass Surgery in Diabetic Patients - THE VICTORY TRIAEUCTR2005-000013-36-ESDr. Olivier F. Bertrand , Laval Hospital280
已完成
2 期
Multicenter randomized double-blind comparison test followed by open-label continuous administration test of NPC-12T for Fibrodysplasia Ossificans ProgressivaFibrodysplasia Ossificans ProgressivaJPRN-UMIN000028429Kyoto University20